| 000 | 01573 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250513132641.0 | ||
| 264 | 0 | _c19980116 | |
| 008 | 199801s 0 0 eng d | ||
| 022 | _a0028-3878 | ||
| 024 | 7 |
_a10.1212/wnl.49.6.1661 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLogigian, E L | |
| 245 | 0 | 0 |
_aReversible cerebral hypoperfusion in Lyme encephalopathy. _h[electronic resource] |
| 260 |
_bNeurology _cDec 1997 |
||
| 300 |
_a1661-70 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBrain Diseases _xcomplications |
| 650 | 0 | 4 |
_aBrain Ischemia _xdiagnosis |
| 650 | 0 | 4 |
_aCeftriaxone _xtherapeutic use |
| 650 | 0 | 4 |
_aCephalosporins _xtherapeutic use |
| 650 | 0 | 4 |
_aCerebrovascular Circulation _xdrug effects |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLyme Disease _xcomplications |
| 650 | 0 | 4 | _aMagnetic Resonance Imaging |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMental Disorders _xetiology |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aReference Values |
| 650 | 0 | 4 | _aTomography, Emission-Computed, Single-Photon |
| 700 | 1 | _aJohnson, K A | |
| 700 | 1 | _aKijewski, M F | |
| 700 | 1 | _aKaplan, R F | |
| 700 | 1 | _aBecker, J A | |
| 700 | 1 | _aJones, K J | |
| 700 | 1 | _aGarada, B M | |
| 700 | 1 | _aHolman, B L | |
| 700 | 1 | _aSteere, A C | |
| 773 | 0 |
_tNeurology _gvol. 49 _gno. 6 _gp. 1661-70 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1212/wnl.49.6.1661 _zAvailable from publisher's website |
| 999 |
_c9378950 _d9378950 |
||